Unique challenges and complexities of paediatric clinical trials explored.
ICON’s World Children’s Day
World Children’s Day is celebrated as an international coming together to advocate for, promote, and celebrate the rights and welfare of children and create dialogue and action plans to build a better world for children. In this webinar, our speakers will explore ongoing regulatory initiatives that aim to promote diversity and inclusion within paediatric therapeutics development.
The RACE for Children Act
Paediatric cancer is the leading cause of death by disease in the US. The intent of the RACE for Children Act is to get more paediatric oncology drugs in the pipeline.
The utility and benefits of adding adolescents to an adult programme
In this webinar, ICON expert, Dr. Martine Dehlinger-Kremer, shares insights on the utility and benefits of adding adolescents to an adult programme, challenges encountered and provides recommendations to overcome these.
The RACE for Children Act prompts more paediatric clinical trials for oncology drug development
In this on-demand webinar, ICON expert Missy Hansen, presents on the paediatric regulatory requirements and study approaches for the development of new medicines, with a particular focus on oncology drug development.
Reflections on paediatric assent: Have we outgrown this concept?
In this webinar, medical ethicists will discuss what investigators, ethics committees, IRBs and – ideally – sponsors can do to reverse this trend and create documents which achieve their intended purpose of allowing a child to understand their trial.
Paediatric Risk Assessment Map
The Paediatric Risk Assessment Map is an interactive, reusable, and shareable tool that helps to identify common risks that exist in clinical trials that include paediatric patients and offers mitigation strategies for consideration.
Speaking Stronger Together: What Every Parent Should Know About Clinical Trials on Apple Podcasts
Clinical trials have a big impact on families, whether the participant is a parent or a child. Heather Peterson, RN, the Pediatric Strategy Liaison at the Center for Pediatric Clinical Development, Drug Development Solutions at ICON, walks us through the considerations and regulations for clinical trials for children and how parents can talk to their children about clinical trials for themselves or their children.
Removing Barriers to Pediatric Clinical Trials
In this on- demand Podcast. Dr Jacqui Whiteway, Senior Director, Centre for Paediatric Clinical Development discusses something very important to her, ‘Removing Barriers to Paediatric Clinical Trials and how creating positive experiences and reducing anxiety for children in clinical trials can benefit the paediatric trial eco system’. Listen to find out more.
Paediatrics media contributions and blogs
Blog: The impact of paediatric medical trauma in clinical trials
Patient-centric paediatric clinical trials can help mitigate the risk of potentially life-long implications of medical trauma and improve trial outcomes.
Media article: Accessibility in rare disease paediatric clinical trials
Strategies to make clinical trials more accessible for Paediatric patients and their families.
Blog: Clinical trials through a child’s eyes: Writing lay summaries for paediatric trial results
Find out how sponsors can create a PLS that is better understandable to paediatric audiences?
Media article: Patient voice, empathy key to paediatric study design
Jacqui Whiteway, Senior Director of the Centre for Paediatric Clinical Development, discusses the unique challenges involved in designing a study when the patients involved are young children.
Blog: Empowering children with education through clinical trials
ICON and Jumo Health have teamed up to share strategies to empower children every day through education, specifically in clinical trials.
Media article: Incorporating patient preference vital to study success
Jayne Galinsky, Senior Outcomes Researcher, shares the importance of learning and assessing patient preferences in clinical research.
Media article: Sharing clinical trial results with paediatric participants
Kirsten Sherman Cervati, Senior Director & Global Head, Pediatric Research Partners, contributes to this media article which discusses the considerations for returning results to paediatric participants.
ICON is invested in bringing safe, effective, paediatric-tested treatments to children. Explore our paediatric experience and how we can support your study from early engagement all the way to approval.